Catherine Burkhart

Dr. Catherine Burkhart has been affiliated with Buffalo BioLabs since 2009. She is currently the Director of Preclinical Studies and is responsible for the planning and oversight of preclinical research. Dr. Burkhart has over 19 years of experience in drug discovery and drug development in the field of oncology. She has extensive experience in cytotoxicity and drug resistance, animal model optimization, toxicity and efficacy testing. Prior to joining Buffalo BioLabs, Dr. Burkhart was a long-time employee of Cleveland BioLabs, Inc in their drug discovery and development programs.